{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T04:18:09Z","timestamp":1775881089048,"version":"3.50.1"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,9,29]],"date-time":"2021-09-29T00:00:00Z","timestamp":1632873600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,9,29]],"date-time":"2021-09-29T00:00:00Z","timestamp":1632873600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1007\/s10072-021-05624-1","type":"journal-article","created":{"date-parts":[[2021,9,29]],"date-time":"2021-09-29T07:04:30Z","timestamp":1632899070000},"page":"697-703","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Galcanezumab effectiveness on comorbid cluster headache and chronic migraine: a prospective case series"],"prefix":"10.1007","volume":"43","author":[{"given":"Luigi Francesco","family":"Iannone","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Davide","family":"Fattori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierangelo","family":"Geppetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"De Cesaris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,9,29]]},"reference":[{"key":"5624_CR1","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s10194-018-0909-4","volume":"19","author":"AL Vollesen","year":"2018","unstructured":"Vollesen AL, Benemei S, Cortese F, Labastida-Ramirez A, Marchese F, Pellesi L, Romoli M, Ashina M, Lampl C, F. School of advanced studies of the European headache (2018) Migraine and cluster headache\u2014the common link. J Headache Pain 19:89","journal-title":"J Headache Pain"},{"key":"5624_CR2","doi-asserted-by":"publisher","first-page":"1866","DOI":"10.1056\/NEJMra1915327","volume":"383","author":"M Ashina","year":"2020","unstructured":"Ashina M (2020) Migraine. N Engl J Med 383:1866\u20131876","journal-title":"N Engl J Med"},{"key":"5624_CR3","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1111\/j.1526-4610.2011.01954.x","volume":"51 Suppl 2","author":"RB Lipton","year":"2011","unstructured":"Lipton RB (2011) Chronic migraine, classification, differential diagnosis, and epidemiology. Headache 51 Suppl 2:77\u201383","journal-title":"Headache"},{"issue":"1","key":"5624_CR4","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/S1474-4422(17)30405-2","volume":"17","author":"J Hoffmann","year":"2018","unstructured":"Hoffmann J, May A (2018) Diagnosis, pathophysiology, and management of cluster headache. Lancet Neurol 17(1):75\u201383. https:\/\/doi.org\/10.1016\/S1474-4422(17)30405-2","journal-title":"Lancet Neurol"},{"key":"5624_CR5","doi-asserted-by":"publisher","first-page":"18006","DOI":"10.1038\/nrdp.2018.6","volume":"4","author":"A May","year":"2018","unstructured":"May A, Schwedt TJ, Magis D, Pozo-Rosich P, Evers S, Wang SJ (2018) Cluster headache. Nat Rev Dis Primers 4:18006","journal-title":"Nat Rev Dis Primers"},{"key":"5624_CR6","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1046\/j.1526-4610.1997.3701021.x","volume":"37","author":"D D\u2019amico","year":"1996","unstructured":"D\u2019amico D, Centonze V, Grazzi L, Leone M, Ricchetti G, Bussone G (1996) Coexistence of migraine and cluster headache: report of 10 cases and possible pathogenetic implications. Headache 37:21\u201325","journal-title":"Headache"},{"key":"5624_CR7","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1177\/0333102415612774","volume":"36","author":"V Lademann","year":"2016","unstructured":"Lademann V, Jansen JP, Evers S, Frese A (2016) Evaluation of guideline-adherent treatment in cluster headache. Cephalalgia 36:760\u2013764","journal-title":"Cephalalgia"},{"key":"5624_CR8","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/0304-3959(94)00097-X","volume":"60","author":"M Fanciullacci","year":"1995","unstructured":"Fanciullacci M, Alessandri M, Figini M, Geppetti P, Michelacci S (1995) Increase in plasma calcitonin gene-related peptide from the extracerebral circulation during nitroglycerin-induced cluster headache attack. Pain 60:119\u2013123","journal-title":"Pain"},{"key":"5624_CR9","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1002\/ana.410280213","volume":"28","author":"PJ Goadsby","year":"1990","unstructured":"Goadsby PJ, Edvinsson L, Ekman R (1990) Vasoactive peptide release in the extracerebral circulation of humans during migraine headache. Ann Neurol 28:183\u2013187","journal-title":"Ann Neurol"},{"key":"5624_CR10","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1001\/jamaneurol.2018.1675","volume":"75","author":"ALH Vollesen","year":"2018","unstructured":"Vollesen ALH, Snoer A, Beske RP, Guo S, Hoffmann J, Jensen RH, Ashina M (2018) Effect of infusion of calcitonin gene-related peptide on cluster headache attacks: a randomized clinical trial. JAMA Neurol 75:1187\u20131197","journal-title":"JAMA Neurol"},{"key":"5624_CR11","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1056\/NEJMoa1813440","volume":"381","author":"PJ Goadsby","year":"2019","unstructured":"Goadsby PJ, Dodick DW, Leone M, Bardos JN, Oakes TM, Millen BA, Zhou C, Dowsett SA, Aurora SK, Ahn AH, Yang JY, Conley RR, Martinez JM (2019) Trial of galcanezumab in prevention of episodic cluster headache. N Engl J Med 381:132\u2013141","journal-title":"N Engl J Med"},{"key":"5624_CR12","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1177\/0333102417741297","volume":"39","author":"S Khan","year":"2019","unstructured":"Khan S, Olesen A, Ashina M (2019) CGRP, a target for preventive therapy in migraine and cluster headache: systematic review of clinical data. Cephalalgia 39:374\u2013389","journal-title":"Cephalalgia"},{"key":"5624_CR13","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1177\/0333102420905321","volume":"40","author":"DW Dodick","year":"2020","unstructured":"Dodick DW, Goadsby PJ, Lucas C, Jensen R, Bardos JN, Martinez JM, Zhou C, Aurora SK, Yang JY, Conley RR, Oakes T (2020) Phase 3 randomized, placebo-controlled study of galcanezumab in patients with chronic cluster headache: results from 3-month double-blind treatment. Cephalalgia 40:935\u2013948","journal-title":"Cephalalgia"},{"key":"5624_CR14","unstructured":"(2018) Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition. Cephalalgia 38:1\u2013211"},{"key":"5624_CR15","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1038\/ncpneuro0122","volume":"2","author":"RB Lipton","year":"2006","unstructured":"Lipton RB (2006) How useful is the HIT-6TM for measuring headache-related disability? Nat Clin Pract Neurol 2:70\u201371","journal-title":"Nat Clin Pract Neurol"},{"key":"5624_CR16","doi-asserted-by":"publisher","first-page":"2428","DOI":"10.1038\/s41598-020-59366-9","volume":"10","author":"JH Sohn","year":"2020","unstructured":"Sohn JH, Park JW, Lee MJ, Chung PW, Chu MK, Chung JM, Ahn JY, Kim BS, Kim SK, Choi YJ, Kim D, Song TJ, Oh K, Moon HS, Park KY, Kim BK, Bae DW, Chung CS, Cho SJ (2020) Clinical factors influencing the impact of cluster headache from a prospective multicenter study. Sci Rep 10:2428","journal-title":"Sci Rep"},{"key":"5624_CR17","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1111\/head.13832","volume":"60","author":"M Silvestro","year":"2020","unstructured":"Silvestro M, Tessitore A, Scotto di Clemente F, Tedeschi G, Russo A (2020) Erenumab efficacy on comorbid cluster headache in patients with migraine: a real-world case series. Headache 60:1187\u20131195","journal-title":"Headache"},{"key":"5624_CR18","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1177\/0333102420949866","volume":"40","author":"R Ruscheweyh","year":"2020","unstructured":"Ruscheweyh R, Broessner G, Gossrau G, Heinze-Kuhn K, Jurgens TP, Kaltseis K, Kamm K, Peikert A, Raffaelli B, Rimmele F, Evers S (2020) Effect of calcitonin gene-related peptide (-receptor) antibodies in chronic cluster headache: results from a retrospective case series support individual treatment attempts. Cephalalgia 40:1574\u20131584","journal-title":"Cephalalgia"},{"issue":"1","key":"5624_CR19","doi-asserted-by":"publisher","first-page":"30","DOI":"10.3390\/brainsci10010030","volume":"10","author":"AC Belin","year":"2020","unstructured":"Belin AC, Ran C, Edvinsson L (2020) Calcitonin gene-related peptide (CGRP) and cluster headache. Brain Sci 10(1):30. https:\/\/doi.org\/10.3390\/brainsci10010030","journal-title":"Brain Sci"},{"key":"5624_CR20","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1177\/0333102419847957","volume":"39","author":"DD Ruff","year":"2019","unstructured":"Ruff DD, Ford JH, Tockhorn-Heidenreich A, Sexson M, Govindan S, Pearlman EM, Wang SJ, Khan A, Aurora SK (2019) Efficacy of galcanezumab in patients with chronic migraine and a history of preventive treatment failure. Cephalalgia 39:931\u2013944","journal-title":"Cephalalgia"},{"key":"5624_CR21","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1016\/S0140-6736(19)31946-4","volume":"394","author":"MD Ferrari","year":"2019","unstructured":"Ferrari MD, Diener HC, Ning X, Galic M, Cohen JM, Yang R, Mueller M, Ahn AH, Schwartz YC, Grozinski-Wolff M, Janka L, Ashina M (2019) Fremanezumab versus placebo for migraine prevention in patients with documented failure to up to four migraine preventive medication classes (FOCUS): a randomised, double-blind, placebo-controlled, phase 3b trial. Lancet 394:1030\u20131040","journal-title":"Lancet"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-021-05624-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10072-021-05624-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-021-05624-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,3]],"date-time":"2022-01-03T18:35:24Z","timestamp":1641234924000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10072-021-05624-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,29]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["5624"],"URL":"https:\/\/doi.org\/10.1007\/s10072-021-05624-1","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,29]]},"assertion":[{"value":"24 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All patients have been previously included in the Italian Registry of Headache (<i>Registro Italiano delle Cefalee, RICe<\/i>), signing an informed consent which included the option to perform headache-related sub-studies. The protocol was reviewed and approved by the Ethical Committee of the University of Florence \u2018Studio RICe, 14591_oss\u2019.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"P.G.: received personal fees from Allergan, Eli Lilly, Novartis, Amgen, TEVA; Grants from Amgen, TEVA, Eli-Lilly, Allergan, Chiesi; Scientific Advisory Board, Endosome Therapeutics; Founding scientist of FloNext srl, Spinoff of the University of Florence. F.D.C. received personal fees from TEVA, Eli Lilly, Novartis. Other authors have no conflicting interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}